| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c54bfbd3f7dc53cbf0e6d08cc0b970c9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2019-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_803628642f7ef8a476fe0839b3a5b80b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3fcfec7c43053ebe2e9f16deb454b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a52252d0dc234d9b34f4ead71b8389c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269cf821f4a201743c6aef1d04ec5f16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9de0f11b259ce8e27ce34a8dd592574 |
| publicationDate |
2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102234754-B1 |
| titleOfInvention |
Foot-and-mouth disease recombinant type A virus inserted with T cell epitope and vaccine composition containing inactivated antigen isolated and purified from this virus |
| abstract |
The present invention relates to a foot-and-mouth disease type A recombinant virus into which a T cell epitope is inserted and a vaccine composition comprising the same, and specifically, to foot-and-mouth disease type A into which a 3A epitope capable of inducing a T cell-mediated-cellular immune response is inserted into foot-and-mouth disease type A. It relates to a recombinant virus and a vaccine composition comprising the same, and can provide a recombinant foot-and-mouth disease virus having a strong defense against foot-and-mouth disease type A virus, and a vaccine composition for preventing foot-and-mouth disease comprising the same as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023090772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230072149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230072150-A |
| priorityDate |
2019-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |